Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes

Whereas lenalidomide is an effective therapy for del(5q) MDS patients, a minority of non-del(5q) MDS patients achieve hematologic improvement with lenalidomide. We used computational biology modeling and digital drug simulation to examine genomic data from 56 non-del(5q) MDS patients treated with le...

Descripción completa

Detalles Bibliográficos
Autores principales: Drusbosky, Leylah M., Cogle, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246771/
https://www.ncbi.nlm.nih.gov/pubmed/32397113
http://dx.doi.org/10.3390/ijms21093323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246771/
https://www.ncbi.nlm.nih.gov/pubmed/32397113
http://dx.doi.org/10.3390/ijms21093323

Ejemplares similares